Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

Hyoung‐gon Lee; Xiongwei Zhu; Rudy J. Castellani; Akihiko Nunomura; George Perry; Mark A. Smith

doi:10.1124/jpet.106.114009

Related publications

Article2021

The Amyloid-β Pathway in Alzheimer’s Disease

Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo

Article2002

The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease

Catherine A. Rottkamp, Craig Atwood, James A. Joseph, Akihiko Nunomura, George Perry, Mark A. Smith

Article2005

Role of Amyloid‐β in Alzheimer's Disease

Mark A. Smith, George Perry

Letter2023

The amyloid-β Pathway in Alzheimer’s Disease: A Plain Language Summary

Harald Hampel, Yan Hu, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo

Chapter in a book2008

Cell Cycle Activation and the Amyloid-β Protein in Alzheimer’s Disease

Katarzyna Gustaw, Gemma Casadesús, Robert P. Friedland, George Perry, Mark A. Smith